Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in HIV-1 Infected Adolescents

NCT02276612 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV

Interventions

DRUG: E/C/F/TAF

Sponsor

Gilead Sciences